A Tumor-Specific Super-Enhancer Drives Immune Evasion by Guiding Synchronous Expression of PD-L1 and PD-L2

Cell Rep. 2020 Jul 28;32(4):108000. doi: 10.1016/j.celrep.2020.108000.
No abstract available

Publication types

  • Published Erratum